Free Cash Flow Chart

View Free Cash Flow for SNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 9.888B
December 31, 2025 8.318B
June 30, 2025 9.170B
December 31, 2024 6.443B
June 30, 2024 4.534B
December 31, 2023 7.577B
June 30, 2023 7.965B
December 31, 2022 8.419B
June 30, 2022 8.362B
December 31, 2021 9.762B
June 30, 2021 7.057B
December 31, 2020 6.163B
June 30, 2020 7.510B
December 31, 2019 6.577B
June 30, 2019 5.604B
December 31, 2018 4.113B
June 30, 2018 5.836B
December 31, 2017 6.375B
June 30, 2017 6.813B
December 31, 2016 6.692B
June 30, 2016 5.411B
December 31, 2015 6.781B
June 30, 2015 8.225B
December 31, 2014 7.888B
June 30, 2014 8.359B
Date Value
December 31, 2013 7.458B
June 30, 2013 5.460B
December 31, 2012 8.350B
June 30, 2012 11.01B
December 31, 2011 10.73B
June 30, 2011 11.05B
December 31, 2010 11.34B
June 30, 2010 9.646B
December 31, 2009 9.777B
June 30, 2009 10.66B
December 31, 2008 9.709B
June 30, 2008 8.388B
December 31, 2007 7.750B
June 30, 2007 6.848B
December 31, 2006 6.600B
June 30, 2006 5.528B
December 31, 2005 6.327B
June 30, 2005 7.155B
December 31, 2004 4.158B
June 30, 2004 2.290B
December 31, 2003 2.230B
June 30, 2003 2.322B
December 31, 2002 1.243B
June 30, 2002 90.41M
December 31, 2001 1.118B

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
AstraZeneca PLC 8.051B
GSK Plc 6.621B
Johnson & Johnson 22.61B
Eli Lilly & Co. 13.56B
Merck & Co., Inc. 16.06B

Free Cash Flow Related Metrics